Liquid biopsy and HRD testing in ovarian cancer KU Leuven
To evaluate the performance of the Leuven Homologous Recombination Deficiency (HRD) assessment on non-tissue specimens, such as plasma and ascites, and compare its reliability in relation to the conventional HRD analysis conducted on tissue samples, specifically direct tumor biopsy. The successful validation of this non-invasive approach to HRD testing would allow the utilization of this method as a reliable alternative. Other applications of ...